Swagat Prasad, Founder

Khushboo Prajapati, Vice President

The pharmaceutical industry is undergoing a shift driven by rising life expectancy, higher disposable incomes, and an aging global population. In the last few years, the focus has moved to faster, targeted R&D addressing emerging health challenges. Companies are optimizing existing platforms to accelerate breakthroughs. Nations like China and other Asian countries are prioritizing self-reliance, focusing on critical ailments to strengthen healthcare resilience. The future of the industry lies in speed, precision, and innovation, driving life-saving advancements.

Equinext understands these dynamics and has robustly positioned itself to address them. As increased life expectancy has created a higher demand for longterm treatments, particularly for chronic conditions like diabetes, arthritis, and heart disease, the company has partnered with research-driven companies to deliver targeted solutions. With this competency at hand, the company has become a leading provider of turnkey pharmaceutical solutions, renowned for ensuring seamless integration across all project phases.

Furthermore, addressing the complexities of pharmaceutical projects, ranging from tablets and capsules to syrups and ointments, the company adopts a structured, client-focused approach to deliver excellence at every stage. Furthermore, Equinext supports pharmaceutical companies in developing these advanced products by providing tailored solutions that align with their objectives. Today, Equinext has created a niche for itself in offering end-to-end support from R&D to implementation.

“We have placed ourselves as a trusted partner in the pharmaceutical sector, enabling companies to innovate and overcome industry complexities. Our value-driven engineering approach ensures functionality at an affordable cost without compromising on quality. We deliver bespoke solutions tailored to each client’s needs, backed by a dedicated and experienced team committed to excellence. By focusing on innovation, efficiency, and understanding the evolving pharmaceutical landscape, we strive to exceed expectations and drive success for our clients while advancing global healthcare access”, highlights Swagat Prasad, Founder, Equinext.

“If we have to look at the company’s engagement process, it begins with meticulous project planning and scope definition, where the company collaborates with clients to gather requirements, understand their needs, and define regulatory, budgetary, and timeline constraints. This ensures a welldefined roadmap aligned with the client’s objectives. Next, the company designs custom solutions tailored to specific goals. By engaging expert consultants, it develops comprehensive plans encompassing equipment selection, software integration, and regulatory compliance frameworks”, adds Khushboo Prajapati, Vice President, Equinext.

Furthermore, procurement plays a critical role in ensuring project success. The company partners with trusted suppliers to secure high-quality components compliant with GMP, FDA, and EMA standards. Strategic supply chain management ensures timely delivery, aligning with project schedules. The engineering and design phase employs advanced 3D modeling to visualize facilities, identify potential challenges, and optimize layouts before implementation, minimizing errors during installation. Next, regulatory compliance is a cornerstone of Equinext’s operations. The company adheres to cGMP and ensures all documentation, including Design, Installation, and Operational Qualifications (DQs, IQs, OQs), is prepared for regulatory approval. During execution, Equinext’s project management team oversees installations, coordinates contractors, and provides on-site training, ensuring systems are seamlessly integrated into existing infrastructure.

Additionally, testing, validation, and commissioning are handled rigorously. Equinext ensures all systems meet specified standards through extensive validation processes, including IQ, OQ, and Performance Qualifications (PQs). Any issues are swiftly resolved through troubleshooting and optimization. Post-installation, the company offers 24/7 support, preventive maintenance, and continuous improvement programs to ensure long-term reliability and efficiency. Moreover, transparency and collaboration underpin Equinext’s approach. A dedicated client  representative ensures open communication, incorporating feedback to align outcomes with client expectations. This commitment to partnership fosters trust and ensures every project reflects the client’s vision. 

By integrating expertise, innovation, and quality at every stage, the company stands as a trusted partner in pharmaceutical solutions. From planning to maintenance, the company’s structured approach guarantees seamless project delivery, making it a preferred choice in the pharmaceutical industry. 

“We provide tailored solutions designed with scalability in mind, crucial for the ever-evolving pharmaceutical market. Our flexible systems accommodate future upgrades, expansions, or modifications. Our structured approach spans project planning, procurement, design, compliance, execution, testing, and post-installation, ensuring integrated, functional, and regulatory-compliant solutions”, signifies Khushboo Prajapati .                                                     

Delivering Bespoke Solutions
Equinext approach integrates client-focused processes with advanced technologies, ensuring scalable and future-proof facilities. The company specializes in addressing complex process engineering requirements through bespoke designs and precise execution. For example, it recently supported a Factory Acceptance Test for MDI (Metered Dose Inhaler) production equipment, a testament to its expertise in handling the most critical pharmaceutical manufacturing needs.

The company’s operations are driven by systematic business units (SBUs) that ensure every client’s unique needs are met. Initial consultations, stakeholder engagement, and site audits form the foundation for defining clear project objectives, whether scaling production, improving energy efficiency, or launching new product lines. Cross-functional teams, including engineers and project managers, deliver custom solutions through detailed process mapping and workflow optimization.

Furthermore, the company’s designs are modular and scalable, allowing facilities to adapt to fluctuating demands without extensive overhauls. Technologies such as AI-enabled systems and advanced automation tools enhance operational efficiency, traceability, and compliance.

Ensuring Utmost Quality Standards
Equinext ensures alignment across design, procurement, installation, and validation through a dedicated project management team. Training and knowledge transfer empower clients to operate facilities effectively, while continuous feedback drives ongoing improvements. The company’s commitment to excellence, industry knowledge, and cuttingedge technology guarantees efficient, high-quality, and regulatory-compliant facilities, positioning Equinext as a trusted partner in the pharmaceutical market. Furthermore, maintaining quality across a diverse portfolio of machinery, APIs, lab equipment, consumables, and packaging requires a robust approach. Equinext’s Quality Management System (QMS), certified by ISO and guided by SOPs, ensures consistency and compliance at every supply chain stage, from procurement to post-sales support.

Adding to this, supplier qualification is key, with rigorous audits and product testing before onboarding. Testing and inspection at every stage, along with traceability through batch tracking systems, ensure products meet specifications. Equinext also collaborates with certified external labs for advanced quality checks aligned with regulatory requirements. Continuous improvement, fuelled by customer feedback, is central to Equinext's strategy, refining SOPs, supplier evaluations, and training programs. This systematic approach ensures consistent adherence to quality and regulatory standards.

At Par with Every Regulatory Standards
At Equinext, managing international regulatory standards is crucial. The company ensures compliance by fostering a culture of continuous learning, R&D, and technology scouting. Its team is dedicated to understanding regional regulations, especially in markets like North Africa, where it has local teams fluent in regional languages and well-versed in specific market needs. The company also collaborates with local distributors to ensure compliance. It follows global quality standards, including ISO certifications, and supports clients during audits. Additionally, Equinext uses digital tools like compliance management software to streamline processes and trace compliance throughout the product lifecycle. The company’s global regulatory network keeps it aligned with international requirements, ensuring that it meets both local and global standards.

Enhancing Air Quality and Contamination Control
HVAC systems are crucial in pharmaceutical manufacturing, where precise control of temperature, humidity, pressure, and air cleanliness is essential. To enhance air quality, Equinext integrates advanced filtration systems. These air quality sensors monitor variables like humidity and pressure in real time, offering enhanced control over the environment. Its centralized Building Management System (BMS) allows remote monitoring, ensuring that even from afar, operators can manage plant conditions, ensuring compliance with FDA and GMP standards.

Customer satisfaction is a top priority for Equinext, wherein, the company emphasizes clear communication, transparency, and proactive support throughout the project lifecycle. Also, Equinext continuously addresses customer feedback, ensuring a closed-loop system that fosters long-term relationships.

Robust Roadmap Ahead
Looking forward, the company plans to lead the turnkey pharmaceutical solutions sector by adopting Industry 4.0 technologies, including automation, robotics, and AI. Furthermore, the company aims to integrate energy-efficient solutions, renewable energy, and scalable facility designs into its projects, all while adhering to regulatory standards.

“Pharmaceutical manufacturing is becoming increasingly global, and strategic partnerships will be critical to success. At Equinext, we focus on creating resilient global supply chains and offering tailored solutions for niche products. We are committed to affordable access to medicines through ‘value- driven engineering’, with a strong emphasis on corporate social responsibility and public health initiatives. Our goal is to continue innovating while maintaining the highest standards in engineering and manufacturing”, concludes Swagat.?